Inhibitors of Cyclin-Dependent Kinases As Anti-Tumor Agents

Informationen zum Autor Paul J. Smith, Eddy W. Yue Zusammenfassung Covering various aspects of cyclin-dependent kinases (CDKs), this volume examines CDKs as molecular and functional entities, their role in various disease processes, and their potential for pharmacological modulation. It explains the integration of cell cycle control pathways, opportunities for targeting, and targets of inhibitors. Inhaltsverzeichnis Section 1: Provides a conceptual framework. Section 2: Focuses on the aspects of CDK Inhibitors as functional anticancer agents. Section 3: Chemistry.

Product details

• Authors: Paul J. (Cardiff University Smith, Paul J. Yue Smith, Eddy W. Smith Yue, YUE EDDY W SMITH PAUL J
• Assisted by: Paul J. Smith (Editor), Paul J. (Cardiff University Smith (Editor), Smith Paul J. (Editor), Eddy W. Yue (Editor), Eddy W. (Incyte Corporation Yue (Editor), Yue Eddy W. (Editor), Claire Simons (Editor of the series), H. John Smith (Editor of the series)
• Publisher: Taylor & Francis Ltd.
• Languages: English
• Product format: Hardback
• Released: 25.10.2006
• EAN: 9780849337741
• ISBN: 978-0-8493-3774-1
• No. of pages: 448
• Series: Enzyme Inhibitors Series; Enzyme Inhibitors Series
• Subjects: Natural sciences, medicine, IT, technology > Medicine > Non-clinical medicine; SCIENCE / Chemistry / General, MEDICAL / Pharmacology, MEDICAL / Biochemistry, biochemistry, chemistry, Pharmacology, Pharmaceutical technology, Pharmaceutical chemistry and technology